U
GEVA

UBS’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

UBS’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q3 		$138K Buy
2,000
+1,020
+104% +$70.4K ﹤0.01% 3977
2014
Q2 		$103K Sell
980
-390
-28% -$41K ﹤0.01% 4136
2014
Q1 		$113K Buy
+1,370
New +$113K ﹤0.01% 4067